MIT Holding is a single source provider of concierge medical
services and products throughout the United States. Through a portfolio of
license, contractual and affiliate agreements, the company offers a portfolio
of services that includes but is in no way limited to the:
• Administering
of intravenous infusions;
• Management
of medical services; and
• Provision
of in-home therapies.
In a press release dated April 27, 2015, the company
revealed that it had achieved positive net income from its operations in 2014,
to the tune of over $14,000. This profit amount signaled significant
improvement from the previous year’s numbers. It’s also a direct consequence of
the company’s renewed focus on its in-home health recovery business and the
resulting growth in overall income generated in 2014 (over $1.1 million).
Many aspects of the structure of MIT Holding’s in-home
health recovery business, which facilitates and assists patients from the time
of their release from a hospital through to a full in-home recovery, were
finalized in 2014. The target audience for the business have been determined to
be those needing infusion for recovery.
With many infusion therapies costing more than $10,000 per
patient, per year and many patients needing special counseling and education
regarding their condition and treatment, there is certainly a market for the
business.
The two most recognized names in the infusion sector, CVS
Health Corp. (NYSE: CVS) and Walgreen Co. (NYSE: WAG), have established
footprints into the home infusion market through a series of strategic
acquisitions that highlight the growing demand for home infusion services. The
usual retail pharmacies and traditional distributors are generally designed to
carry inventories of low cost, high volume products, while MIT Holding’s
platform is based on the delivery of high cost, low volume specialty
pharmaceuticals that have specialized handling and administration requirements.
Today’s United States home infusion market has been
estimated at around $16 billion and is forecasted to reach approximately $27
billion by 2020, according to Harris Williams & Co. At a compound annual
growth rate of approximately 9% per year, this could mean a significant market
opportunity for MIT Holding. Furthermore, the company is anticipating that the
demand for low cost, high quality home care will increase as paying patients
become aware that they could realize up to 90% in savings on infusion services
performed in the home versus in the hospital and that, as a result, this will
result in continued growth for its in-home health recovery business. It is
little wonder that this is an area of significant focus in its operations.
For more information, visit the company’s website at
www.mitholdinginc.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment